2021
Inhibin-positive hepatic carcinoma: proposal for a solid-tubulocystic variant of intrahepatic cholangiocarcinoma
Wen KW, Joseph NM, Srivastava A, Saunders TA, Jain D, Rank J, Feely M, Zarrinpar A, Al Diffalha S, Shyn PB, Graham RP, Drage MG, Kakar S. Inhibin-positive hepatic carcinoma: proposal for a solid-tubulocystic variant of intrahepatic cholangiocarcinoma. Human Pathology 2021, 116: 82-93. PMID: 34298064, DOI: 10.1016/j.humpath.2021.07.004.Peer-Reviewed Original ResearchConceptsSex cord-stromal tumorsCapture-based next-generation sequencingIntrahepatic cholangiocarcinomaNext-generation sequencingSolitary large massPrimary liver carcinomaPrimary liver neoplasmRecurrent genetic abnormalitiesThyroid follicular tumorsAggressive courseRecurrent genomic changesCystic areasImmunophenotypic featuresRare tumorThyroid originCytologic atypiaLiver neoplasmsHepatocellular carcinomaPatchy stainingHepatic carcinomaLiver carcinomaMorphologic patternsHepatocellular differentiationFollicular tumorsSmall series
2010
Malignant tumours of gallbladder and extrahepatic bile ducts
Flood T, Jain D, Marginean E. Malignant tumours of gallbladder and extrahepatic bile ducts. Diagnostic Histopathology 2010, 16: 360-370. DOI: 10.1016/j.mpdhp.2010.06.003.Peer-Reviewed Original ResearchExtrahepatic bile duct cancerExtrahepatic bile ductBile ductGallbladder cancerBiliary tract neoplasmsBile duct cancerStage of diseaseUseful prognostic indicatorManagement of cancerDuct cancerOlder patientsAggressive courseFavorable prognosisClinical presentationHistologic typePancreaticobiliary typeChronic inflammationHistologic featuresPoor prognosisHistologic gradePrognostic indicatorGeographic predilectionHistologic variantsBiliary epitheliumMalignant tumors